The Scientist

» cancer, microbiology and developmental biology

Most Recent

Despite an overall decrease in the number of US cancer deaths, some cancer types are on the rise, and disparities remain between genders and ethnicities.

0 Comments

image: Angela Brooks: Splicing Specialist

Angela Brooks: Splicing Specialist

By | April 1, 2017

At the University of California, Santa Cruz, the researcher combs the cancer genome, looking for weaknesses.

0 Comments

image: Book Excerpt from <em>The Politics of Cancer</em>

Book Excerpt from The Politics of Cancer

By | April 1, 2017

In Chapter 2, “Identifying the Culprits,” author Wendy Whitman Cobb describes how small-government, anti-regulation conservatism can hinder the fight against cancer.

0 Comments

image: Cancer and Its Milieu

Cancer and Its Milieu

By | April 1, 2017

Lawrence Berkeley National Laboratory researcher and April profilee Mina Bissell explains the intricacies of how cancer takes hold in a body.

0 Comments

image: Cooking Up Cancer?

Cooking Up Cancer?

By | April 1, 2017

Overcooked potatoes and burnt toast contain acrylamide, a potential carcinogen that researchers have struggled to reliably link to human cancers.

1 Comment

Mice engineered to overproduce the organelles involved in cell division spontaneously develop malignancies.

0 Comments

image: How Will Cancer Research Fare Under Trump?

How Will Cancer Research Fare Under Trump?

By | April 1, 2017

The new administration has not yet made its intentions clear.

0 Comments

image: Making CAR T-Cell Therapy Safer

Making CAR T-Cell Therapy Safer

By | April 1, 2017

Following a spate of patient deaths in clinical trials testing modified T cells for the treatment of cancer, researchers work to reduce the treatment’s toxicity without sacrificing efficacy.

0 Comments

image: Notable Science Quotes

Notable Science Quotes

By | April 1, 2017

Eugene Garfield, the cancer moonshot, employee genetic testing, and more

0 Comments

Measuring PD-L1 levels was a great start. Now we need to quantify more protein biomarkers, assess the tumor mutational landscape, and examine immune cell signatures, too.

0 Comments

Popular Now

  1. Consilience, Episode 3: Cancer, Obscured
  2. RNAi’s Future in Drug-Target Screening
    News Analysis RNAi’s Future in Drug-Target Screening

    A recent CRISPR study contradicted years of RNA interference research on a well-studied cancer drug target. But is it the last nail in the coffin for RNAi as a screening tool? 

  3. A History of Screening for Natural Products to Fight Cancer
  4. Human Cord Plasma Protein Boosts Cognitive Function in Older Mice
AAAS